IκB kinase complexes: gateways to NF-κB activation and transcription
暂无分享,去创建一个
[1] Zhijian J. Chen,et al. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. , 2004, Molecular cell.
[2] Jae-Hyuck Shim,et al. A Novel Ubiquitin-like Domain in IκB Kinase β Is Required for Functional Activity of the Kinase* , 2004, Journal of Biological Chemistry.
[3] G. Courtois,et al. Two Carboxyl-terminal Activation Regions of Epstein-Barr Virus Latent Membrane Protein 1 Activate NF-κB through Distinct Signaling Pathways in Fibroblast Cell Lines* , 2003, Journal of Biological Chemistry.
[4] M. Pierotti,et al. The TFG protein, involved in oncogenic rearrangements, interacts with TANK and NEMO, two proteins involved in the NF‐κB pathway , 2006, Journal of cellular physiology.
[5] L. Cantley,et al. The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMO , 2004, Current Biology.
[6] R. Brink,et al. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. , 2004, Immunity.
[7] A. Ciechanover,et al. Mechanism of processing of the NF-κB2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCFβ-TrCP ubiquitin ligase , 2004, Oncogene.
[8] Yue Sun,et al. Identification of β-Arrestin2 as a G Protein-Coupled Receptor-Stimulated Regulator of NF-κB Pathways , 2004 .
[9] M. Emi,et al. Differential expression of multiple isoforms of the ELKS mRNAs involved in a papillary thyroid carcinoma , 2002, Genes, chromosomes & cancer.
[10] X. Hua,et al. Act1, an NF-κB-activating protein , 2000 .
[11] Shao-Cong Sun,et al. Regulation of the Deubiquitinating Enzyme CYLD by IκB Kinase Gamma-Dependent Phosphorylation , 2005, Molecular and Cellular Biology.
[12] M. Karin,et al. The Carboxyl-Terminal Region of IκB Kinase γ (IKKγ) Is Required for Full IKK Activation , 2002, Molecular and Cellular Biology.
[13] M. Karin,et al. Activation of IKK by thymosin α1 requires the TRAF6 signalling pathway , 2005 .
[14] D. Goeddel,et al. Identification and Characterization of an IκB Kinase , 1997, Cell.
[15] G. Pei,et al. Association of β-arrestin and TRAF6 negatively regulates Toll-like receptor–interleukin 1 receptor signaling , 2006, Nature Immunology.
[16] G. Stark,et al. Mutant Cells That Do Not Respond to Interleukin-1 (IL-1) Reveal a Novel Role for IL-1 Receptor-Associated Kinase , 1999, Molecular and Cellular Biology.
[17] M. Mayo,et al. IκB Kinase α-Mediated Derepression of SMRT Potentiates Acetylation of RelA/p65 by p300 , 2006, Molecular and Cellular Biology.
[18] Desmond J. Tobin,et al. NF-κB transmits Eda A1/EdaR signalling to activate Shh and cyclin D1 expression, and controls post-initiation hair placode down growth , 2006, Development.
[19] A. Ashworth,et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members , 2003, Nature.
[20] D. Goeddel,et al. The IκB Function of NF-κB2 p100 Controls Stimulated Osteoclastogenesis , 2003, The Journal of experimental medicine.
[21] E. Schmidt,et al. IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development , 2001, Cell.
[22] Bernd R. Binder,et al. Signaling Molecules of the NF-κB Pathway Shuttle Constitutively between Cytoplasm and Nucleus* , 2002, The Journal of Biological Chemistry.
[23] R. Gaynor,et al. Formation of an IKKalpha-dependent transcription complex is required for estrogen receptor-mediated gene activation. , 2005, Molecular cell.
[24] R. Gaynor,et al. Regulation of β-Catenin Function by the IκB Kinases* , 2001, The Journal of Biological Chemistry.
[25] Y. Matsuo,et al. The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma. , 2004, Structure.
[26] Ryuji Kobayashi,et al. IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a , 2004, Cell.
[27] R. Gaynor,et al. Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression , 2003, Nature.
[28] Inder M. Verma,et al. Enhanced NF-κB activation and cellular function in macrophages lacking IκB kinase 1 (IKK1) , 2005 .
[29] Mike Rothe,et al. IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK , 1997 .
[30] F. Weih,et al. RelB is required for Peyer's patch development: differential regulation of p52–RelB by lymphotoxin and TNF , 2003, The EMBO journal.
[31] P. Ramakrishnan,et al. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] M. Karin. How NF-κB is activated: the role of the IκB kinase (IKK) complex , 1999, Oncogene.
[33] Zhijian J. Chen,et al. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. , 2004, Molecular cell.
[34] Ebrahim Zandi,et al. Regulation of IκB Kinase (IKK) Complex by IKKγ-dependent Phosphorylation of the T-loop and C Terminus of IKKβ* , 2006, Journal of Biological Chemistry.
[35] P. Ramakrishnan,et al. Receptor-Specific Signaling for Both the Alternative and the Canonical NF-κB Activation Pathways by NF-κB-Inducing Kinase , 2004 .
[36] A. Leonardi,et al. CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[37] Toby Lawrence,et al. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation , 2005, Nature.
[38] E. Meurs,et al. PKR Stimulates NF-κB Irrespective of Its Kinase Function by Interacting with the IκB Kinase Complex , 2000, Molecular and Cellular Biology.
[39] C. Scheidereit,et al. Shared Pathways of IκB Kinase-Induced SCFβTrCP-Mediated Ubiquitination and Degradation for the NF-κB Precursor p105 and IκBα , 2001, Molecular and Cellular Biology.
[40] G. Courtois,et al. Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation , 1998, Cell.
[41] Chi A. Ma,et al. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia , 2001, Nature Immunology.
[42] G. Xiao,et al. Induction of p100 Processing by NF-κB-inducing Kinase Involves Docking IκB Kinase α (IKKα) to p100 and IKKα-mediated Phosphorylation* , 2004, Journal of Biological Chemistry.
[43] G. Courtois,et al. NEMO Trimerizes through Its Coiled-coil C-terminal Domain* , 2002, The Journal of Biological Chemistry.
[44] R. Gaynor,et al. IKKα Regulates Estrogen-induced Cell Cycle Progression by Modulating E2F1 Expression* , 2006, Journal of Biological Chemistry.
[45] M. Rowe,et al. Latent Membrane Protein 1 of Epstein-Barr Virus Stimulates Processing of NF-κB2 p100 to p52* , 2003, Journal of Biological Chemistry.
[46] C. Lim,et al. Inhibition of nuclear factor κB activity by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herpesvirus , 2004, Oncogene.
[47] B. Huhse,et al. CD40 regulates the processing of NF‐κB2 p100 to p52 , 2002 .
[48] G. Courtois,et al. ATM Is Required for IκB Kinase (IKK) Activation in Response to DNA Double Strand Breaks* , 2000, The Journal of Biological Chemistry.
[49] S. Ghosh,et al. Characterization of the IκB-kinase NEMO Binding Domain* , 2002, The Journal of Biological Chemistry.
[50] L. Neckers,et al. Disruption of Hsp90 Function Results in Degradation of the Death Domain Kinase, Receptor-interacting Protein (RIP), and Blockage of Tumor Necrosis Factor-induced Nuclear Factor-κB Activation* , 2000, The Journal of Biological Chemistry.
[51] A. Hoffmann,et al. The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .
[52] René Bernards,et al. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB , 2003, Nature.
[53] Y. You,et al. Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation* , 2006, Journal of Biological Chemistry.
[54] S. Srinivasula,et al. Activation of the IκB Kinases by RIP via IKKγ/NEMO-mediated Oligomerization* , 2000, The Journal of Biological Chemistry.
[55] S. Akira,et al. Modulation of TLR4 Signaling by a Novel Adaptor Protein Signal-Transducing Adaptor Protein-2 in Macrophages1 , 2006, The Journal of Immunology.
[56] J. Knop,et al. Effects of IL‐1 receptor‐associated kinase (IRAK) expression on IL‐1 signaling are independent of its kinase activity , 1999, FEBS letters.
[57] J. Caamaño,et al. Regulation of secondary lymphoid organ development by the nuclear factor‐κB signal transduction pathway , 2003, Immunological reviews.
[58] J. Caamaño,et al. Epstein–Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-κB2 to p52 via an IKKγ/NEMO-independent signalling pathway , 2003, Oncogene.
[59] Ralf Bartenschlager,et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.
[60] S. Miyamoto,et al. The Zinc Finger Domain of NEMO Is Selectively Required for NF-κB Activation by UV Radiation and Topoisomerase Inhibitors , 2002, Molecular and Cellular Biology.
[61] David M. Rothwarf,et al. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.
[62] J. Dixon,et al. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. , 2000, Science.
[63] E. Harhaj,et al. Retroviral oncoprotein Tax induces processing of NF‐κB2/p100 in T cells: evidence for the involvement of IKKα , 2001 .
[64] W. Walters,et al. NIBP, a Novel NIK and IKKβ-binding Protein That Enhances NF-κB Activation* , 2005, Journal of Biological Chemistry.
[65] W. Greene,et al. Shaping the nuclear action of NF-κB , 2004, Nature Reviews Molecular Cell Biology.
[66] W. Welch,et al. Stress-Induced Inhibition of the NF-κB Signaling Pathway Results from the Insolubilization of the IκB Kinase Complex following Its Dissociation from Heat Shock Protein 901 , 2005, The Journal of Immunology.
[67] Ramin Massoumi,et al. Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling , 2006, Cell.
[68] J. Tschopp,et al. PIDD Mediates NF-κB Activation in Response to DNA Damage , 2005, Cell.
[69] Kyu-Jin Park,et al. Hepatitis C Virus Nonstructural 5B Protein Regulates Tumor Necrosis Factor Alpha Signaling through Effects on Cellular IκB Kinase , 2006, Molecular and Cellular Biology.
[70] G. Courtois,et al. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination , 2003, Nature.
[71] A. Smahi,et al. NEMO/IKK?: linking NF-?B to human disease , 2001 .
[72] S. Srinivasula,et al. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation , 2006, Nature Cell Biology.
[73] T. Saitoh,et al. TWEAK Induces NF-κB2 p100 Processing and Long Lasting NF-κB Activation* , 2003, Journal of Biological Chemistry.
[74] M. Diaz-Meco,et al. The p62 Scaffold Regulates Nerve Growth Factor-induced NF-κB Activation by Influencing TRAF6 Polyubiquitination* , 2005, Journal of Biological Chemistry.
[75] T. Kawabe,et al. Helicobacter pylori Activates NF-κB via the Alternative Pathway in B Lymphocytes , 2005, The Journal of Immunology.
[76] W. Greene,et al. The Proto-Oncogene Cot Kinase Participates in CD3/CD28 Induction of NF-κB Acting through the NF-κB-Inducing Kinase and IκB Kinases , 1999 .
[77] David Baltimore,et al. Two Pathways to NF-κB , 2002 .
[78] M. Thome. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation , 2004, Nature Reviews Immunology.
[79] R. Lefkowitz,et al. β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα , 2004 .
[80] K. Jeang,et al. Human T-lymphotropic Virus Type I Tax Activates I-κB Kinase by Inhibiting I-κB Kinase-associated Serine/Threonine Protein Phosphatase 2A* , 2003, The Journal of Biological Chemistry.
[81] Lin-Feng Chen,et al. NF-κB Is Essential for Induction of CYLD, the Negative Regulator of NF-κB , 2004, Journal of Biological Chemistry.
[82] Douglas B. Evans,et al. Mechanisms of Proinflammatory Cytokine-Induced Biphasic NF-κB Activation. , 2003 .
[83] C. Scheidereit,et al. The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators , 1999, Oncogene.
[84] Zhijian J. Chen,et al. TRAF2: A Double-Edged Sword? , 2005, Science's STKE.
[85] A. Ryo,et al. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. , 2003, Molecular cell.
[86] B. Mordmüller,et al. Lymphotoxin and lipopolysaccharide induce NF‐κB‐p52 generation by a co‐translational mechanism , 2003, EMBO reports.
[87] Rui Li,et al. IκB Kinase α Regulates Subcellular Distribution and Turnover of Cyclin D1 by Phosphorylation* , 2005, Journal of Biological Chemistry.
[88] S. Srinivasula,et al. vCLAP, a Caspase-recruitment Domain-containing Protein of Equine Herpesvirus-2, Persistently Activates the IκB Kinases through Oligomerization of IKKγ* , 2001, The Journal of Biological Chemistry.
[89] Gabriel Pineda,et al. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. , 2006, Molecular cell.
[90] L. Salmena,et al. Requirement for Caspase-8 in NF-κB Activation by Antigen Receptor , 2005, Science.
[91] R. Gaynor,et al. IκB kinases: key regulators of the NF-κB pathway , 2004 .
[92] S. Westerheide,et al. The Putative Oncoprotein Bcl-3 Induces Cyclin D1 To Stimulate G1 Transition , 2001, Molecular and Cellular Biology.
[93] D. Seshasayee,et al. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. , 2002, Immunity.
[94] Wei‐Chien Huang,et al. Tyrosine Phosphorylation of I-κB Kinase α/β by Protein Kinase C-Dependent c-Src Activation Is Involved in TNF-α-Induced Cyclooxygenase-2 Expression1 , 2003, The Journal of Immunology.
[95] M. Cortés,et al. ATM and the Catalytic Subunit of DNA-Dependent Protein Kinase Activate NF-κB through a Common MEK/Extracellular Signal-Regulated Kinase/p90rsk Signaling Pathway in Response to Distinct Forms of DNA Damage , 2004, Molecular and Cellular Biology.
[96] P. Patterson,et al. Activation of the IκB Kinase Complex and Nuclear Factor-κB Contributes to Mutant Huntingtin Neurotoxicity , 2004, The Journal of Neuroscience.
[97] C. Scheidereit,et al. Requirement of Hsp90 activity for IκB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation , 2004, Oncogene.
[98] M. Mann,et al. IκB Kinase (IKK)-Associated Protein 1, a Common Component of the Heterogeneous IKK Complex , 1999, Molecular and Cellular Biology.
[99] C. Bracken,et al. Activity of Hypoxia-inducible Factor 2α Is Regulated by Association with the NF-κB Essential Modulator* , 2005, Journal of Biological Chemistry.
[100] S. Soond,et al. TRUSS, a Novel Tumor Necrosis Factor Receptor 1 Scaffolding Protein That Mediates Activation of the Transcription Factor NF-κB , 2003, Molecular and Cellular Biology.
[101] U. Siebenlist,et al. Control of lymphocyte development by nuclear factor-κB , 2005, Nature Reviews Immunology.
[102] S. Ghosh,et al. PDK1 Nucleates T Cell Receptor-Induced Signaling Complex for NF-κB Activation , 2005, Science.
[103] Jonathan D. Hron,et al. Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. , 2004, Immunity.
[104] Giulio Superti-Furga,et al. A physical and functional map of the human TNF-α/NF-κB signal transduction pathway , 2004, Nature Cell Biology.
[105] Y. Xiong,et al. A role for NEMO/IKKγ Ubiquitination in the activation of the IκB kinase complex by TNF-α , 2003 .
[106] Honglin Zhou,et al. Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation , 2005, The Journal of experimental medicine.
[107] T. Mak,et al. Essential role for IκB kinase β in remodeling carma1-bcl10-malt1 complexes upon T cell activation , 2006 .
[108] C. Scheidereit,et al. Tetrameric Oligomerization of IκB Kinase γ (IKKγ) Is Obligatory for IKK Complex Activity and NF-κB Activation , 2003, Molecular and Cellular Biology.
[109] S. Ley,et al. Functions of NF-?B1 and NF-?B2 in immune cell biology , 2004 .
[110] T. Maniatis,et al. Site-Specific Phosphorylation of IκBα by a Novel Ubiquitination-Dependent Protein Kinase Activity , 1996, Cell.
[111] B. Piret,et al. The ATM protein is required for sustained activation of NF-κB following DNA damage , 1999, Oncogene.
[112] A. Leonardi,et al. Association of the Adaptor TANK with the IκB Kinase (IKK) Regulator NEMO Connects IKK Complexes with IKKε and TBK1 Kinases* , 2002, The Journal of Biological Chemistry.
[113] R. Gaynor,et al. Protein Phosphatase 2Cβ Association with the IκB Kinase Complex Is Involved in Regulating NF-κB Activity* , 2003, Journal of Biological Chemistry.
[114] M. C. Cardoso,et al. Inhibition of NF-kappaB by a TAT-NEMO-binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis. , 2003, Blood.
[115] E. Zandi,et al. The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.
[116] I. Screpanti,et al. Notch3 and pre‐TCR interaction unveils distinct NF‐κB pathways in T‐cell development and leukemia , 2006, The EMBO journal.
[117] Zhijian J. Chen. Ubiquitin signalling in the NF-κB pathway , 2005, Nature Cell Biology.
[118] D. Goeddel,et al. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. , 1996, Immunity.
[119] S. Ghosh,et al. Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex , 2000 .
[120] E. C. Snow,et al. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. , 2004, Immunity.
[121] E. Harhaj,et al. Regulation of the NF-κB-inducing Kinase by Tumor Necrosis Factor Receptor-associated Factor 3-induced Degradation* , 2004, Journal of Biological Chemistry.
[122] S. Akira,et al. Essential function for the kinase TAK1 in innate and adaptive immune responses , 2005, Nature Immunology.
[123] R. Gaynor,et al. Heat Shock Protein 27 Association with the IκB Kinase Complex Regulates Tumor Necrosis Factor α-induced NF-κB Activation* , 2003, Journal of Biological Chemistry.
[124] Koji Okabe,et al. Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo , 2004, Nature Medicine.
[125] T. Tsuruo,et al. 3-Phosphoinositide-dependent Protein Kinase-1-mediated IκB Kinase β (IKKB) Phosphorylation Activates NF-κB Signaling* , 2005, Journal of Biological Chemistry.
[126] S. L. Wong,et al. Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.
[127] C. Scheidereit,et al. A pervasive role of ubiquitin conjugation in activation and termination of IκB kinase pathways , 2005, EMBO reports.
[128] Christian Stehlik,et al. PAN1/NALP2/PYPAF2, an Inducible Inflammatory Mediator That Regulates NF-κB and Caspase-1 Activation in Macrophages* , 2004, Journal of Biological Chemistry.
[129] Zhijian J. Chen,et al. TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[130] S. Gringhuis,et al. Convergent Actions of IκB Kinase β and Protein Kinase Cδ Modulate mRNA Stability through Phosphorylation of 14-3-3β Complexed with Tristetraprolin , 2005, Molecular and Cellular Biology.
[131] Richard B. Gaynor,et al. Hsp27 association with the IKK complex regulates TNF-α-induced NF-κB activation , 2003 .
[132] A. Klippel,et al. The IκB Kinase (IKK) Complex Is Tripartite and Contains IKKγ but Not IKAP as a Regular Component* , 2000, The Journal of Biological Chemistry.
[133] Matthew T Wheeler,et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.
[134] G. W. Peet,et al. IKKα, IKKβ, and NEMO/IKKγ Are Each Required for the NF-κB-mediated Inflammatory Response Program* , 2002, The Journal of Biological Chemistry.
[135] G. Haegeman,et al. Recruitment of IκBα to the hes1 promoter is associated with transcriptional repression , 2004 .
[136] S. Howell,et al. KSHV vFLIP binds to IKK-γ to activate IKK , 2003, Journal of Cell Science.
[137] Ki-Young Lee,et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. , 2005, Genes & development.
[138] K. Marcu,et al. Gene Expression Profiling in Conjunction with Physiological Rescues of IKKα-null Cells with Wild Type or Mutant IKKα Reveals Distinct Classes of IKKα/NF-κB-dependent Genes* , 2005, Journal of Biological Chemistry.
[139] W. Liao,et al. The essential role of MEKK3 in TNF-induced NF-κB activation , 2001, Nature Immunology.
[140] S. Saccani,et al. Modulation of NF-κB Activity by Exchange of Dimers , 2003 .
[141] Ivan Dikic,et al. Ubiquitylation and cell signaling , 2005, The EMBO journal.
[142] K. Guan,et al. The Zinc Finger Mutation C417R of I-κB Kinase γ Impairs Lipopolysaccharide- and TNF-Mediated NF-κB Activation through Inhibiting Phosphorylation of the I-κB Kinase β Activation Loop1 , 2004, The Journal of Immunology.
[143] Somasekar Seshagiri,et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.
[144] R. Surabhi,et al. TAK1 is Critical for IκB Kinase-mediated Activation of the NF-κB Pathway , 2003 .
[145] Z. Zhai,et al. The Ret Finger Protein Inhibits Signaling Mediated by the Noncanonical and Canonical IκB Kinase Family Members1 , 2006, The Journal of Immunology.
[146] M. Karin,et al. The α and β Subunits of IκB Kinase (IKK) Mediate TRAF2-Dependent IKK Recruitment to Tumor Necrosis Factor (TNF) Receptor 1 in Response to TNF , 2001, Molecular and Cellular Biology.
[147] Zhijian J. Chen,et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK , 2001, Nature.
[148] C. Seeger,et al. Cardif: A protein central to innate immunity is inactivated by the HCV NS3 serine protease , 2006, Hepatology.
[149] Jian-Dong Li,et al. The Tumor Suppressor Cylindromatosis (CYLD) Acts as a Negative Regulator for Toll-like Receptor 2 Signaling via Negative Cross-talk with TRAF6 and TRAF7* , 2005, Journal of Biological Chemistry.
[150] A. Leonardi,et al. Role of the adaptor protein CIKS in the activation of the IKK complex. , 2003, Biochemical and biophysical research communications.
[151] Jianping Ye,et al. Serine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor κB Kinase Complex* 210 , 2002, The Journal of Biological Chemistry.
[152] M. Karin,et al. IκB kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesis , 2004, Nature.
[153] B. Marinari,et al. Vav-1 and the IKKα Subunit of IκB Kinase Functionally Associate to Induce NF-κB Activation in Response to CD28 Engagement1 , 2003, The Journal of Immunology.
[154] Zhijian J. Chen,et al. Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.
[155] R. Gaynor,et al. Nuclear Role of IκB Kinase-γ/NF-κB Essential Modulator (IKKγ/NEMO) in NF-κB-dependent Gene Expression* , 2004, Journal of Biological Chemistry.
[156] G Cantarella,et al. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. , 2000, Immunity.
[157] Robert S. Carter,et al. Positive Regulation of IκB Kinase Signaling by Protein Serine/Threonine Phosphatase 2A* , 2005, Journal of Biological Chemistry.
[158] Andre Levchenko,et al. Transient IκB Kinase Activity Mediates Temporal NF-κB Dynamics in Response to a Wide Range of Tumor Necrosis Factor-α Doses* , 2006, Journal of Biological Chemistry.
[159] M. Karin,et al. The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .
[160] B. Aronow,et al. Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers , 2004 .
[161] J. Qin,et al. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. , 2004, Molecular cell.
[162] R. Gaynor,et al. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. , 2003, Molecular biology of the cell.
[163] S. Saccani,et al. p38-dependent marking of inflammatory genes for increased NF-κB recruitment , 2002, Nature Immunology.
[164] M. Karin,et al. IKKα controls formation of the epidermis independently of NF-κB , 2001, Nature.
[165] Honglin Zhou,et al. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO , 2004, Nature.
[166] Jürgen R. Müller,et al. Lymphotoxin β Receptor Induces Sequential Activation of Distinct NF-κB Factors via Separate Signaling Pathways* , 2003, The Journal of Biological Chemistry.
[167] Y. Xiong,et al. A Role for NF-κB Essential Modifier/IκB Kinase-γ (NEMO/IKKγ) Ubiquitination in the Activation of the IκB Kinase Complex by Tumor Necrosis Factor-α* , 2003, Journal of Biological Chemistry.
[168] E. Zandi,et al. Complete reconstitution of human IkappaB kinase (IKK) complex in yeast. Assessment of its stoichiometry and the role of IKKgamma on the complex activity in the absence of stimulation. , 2001, The Journal of biological chemistry.
[169] D. Hohl,et al. The Tumor Suppressor CYLD Interacts with TRIP and Regulates Negatively Nuclear Factor κB Activation by Tumor Necrosis Factor , 2003, The Journal of experimental medicine.
[170] P. Krammer,et al. Activation or suppression of NFκB by HPK1 determines sensitivity to activation‐induced cell death , 2005 .
[171] K. Nakayama,et al. Common Pathway for the Ubiquitination of IκBα, IκBβ, and IκBε Mediated by the F-Box Protein FWD1* , 1999, The Journal of Biological Chemistry.
[172] K. Jeang,et al. An Alternative Splice Product of IκB Kinase (IKKγ), IKKγ-Δ, DifferentiallyMediates Cytokine and Human T-Cell Leukemia Virus Type 1 Tax-Induced NF-κB Activation , 2006, Journal of Virology.
[173] C. Shi,et al. Tumor Necrosis Factor (TNF)-induced Germinal Center Kinase-related (GCKR) and Stress-activated Protein Kinase (SAPK) Activation Depends upon the E2/E3 Complex Ubc13-Uev1A/TNF Receptor-associated Factor 2 (TRAF2)* , 2003, The Journal of Biological Chemistry.
[174] Z. Zhai,et al. CSN3 interacts with IKKγ and inhibits TNF‐ but not IL‐1‐induced NF‐κB activation , 2001 .
[175] Sankar Ghosh,et al. Signaling to NF-kappaB. , 2004, Genes & development.
[176] G. Courtois,et al. The Trimerization Domain of Nemo Is Composed of the Interacting C-terminal CC2 and LZ Coiled-coil Subdomains* , 2004, Journal of Biological Chemistry.
[177] J. Christman,et al. Expression by Direct Interaction with I B Activation and Cyclooxygenase-2 Κ Nf- Hepatitis C Virus Core Protein Suppresses , 2004 .
[178] D. Green,et al. The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways , 2002 .
[179] E. Kieff,et al. IκB kinase β phosphorylates Dok1 serines in response to TNF, IL-1, or γ radiation , 2004 .
[180] A. Manning,et al. Fanconi anemia protein complex is a novel target of the IKK signalsome , 2002, Journal of cellular biochemistry.
[181] Lu Zhang,et al. Hsp70 promotes TNF-mediated apoptosis by binding IKKγ and impairing NF-κB survival signaling , 2004 .
[182] P. Chaudhary,et al. Activation of alternative NF-κB pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1β-converting enzyme inhibitory protein (vFLIP) , 2004 .
[183] A. Leonardi,et al. Physical and Functional Interaction of CARMA1 and CARMA3 with Iκ Kinase γ-NFκB Essential Modulator* , 2004, Journal of Biological Chemistry.
[184] D. Goeddel,et al. TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. , 2002, Molecular cell.
[185] S. Saccani,et al. Degradation of Promoter-bound p65/RelA Is Essential for the Prompt Termination of the Nuclear Factor κB Response , 2004, The Journal of experimental medicine.
[186] E. Harhaj,et al. NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100 , 2001 .
[187] J. Qin,et al. Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator Activity by IκB Kinase , 2002, Molecular and Cellular Biology.
[188] A. Ashworth,et al. Identification of the familial cylindromatosis tumour-suppressor gene , 2000, Nature Genetics.
[189] A. Baldwin,et al. IκB Kinase α and p65/RelA Contribute to Optimal Epidermal Growth Factor-induced c-fos Gene Expression Independent of IκBα Degradation* , 2004, Journal of Biological Chemistry.
[190] R. Hay,et al. SUMO: a history of modification. , 2005, Molecular cell.
[191] C. Cheng‐Mayer,et al. Molecular Mechanism of hTid-1, the Human Homolog of Drosophila Tumor Suppressor l(2)Tid, in the Regulation of NF-κB Activity and Suppression of Tumor Growth , 2005, Molecular and Cellular Biology.
[192] H. Nakano,et al. The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation. , 2003, Genes & development.
[193] Matthias Mann,et al. IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .
[194] T. Maniatis,et al. NF-(cid:1) B signaling pathways in mammalian and insect innate immunity , 2001 .
[195] Shao-Cong Sun,et al. Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD* , 2004, Journal of Biological Chemistry.
[196] Concepción Rodríguez-Esteban,et al. Zebrafish IκB Kinase 1 Negatively Regulates NF-κB Activity , 2005, Current Biology.
[197] Christopher K. Glass,et al. Exchange of N-CoR Corepressor and Tip60 Coactivator Complexes Links Gene Expression by NF-κB and β-Amyloid Precursor Protein , 2002, Cell.
[198] S. Miyamoto,et al. Sequential Modification of NEMO/IKKγ by SUMO-1 and Ubiquitin Mediates NF-κB Activation by Genotoxic Stress , 2003, Cell.
[199] Hong-shan Wang,et al. BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells , 2002, Nature Immunology.
[200] Michael Karin,et al. Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.
[201] R. Tibbetts,et al. Molecular Linkage Between the Kinase ATM and NF-κB Signaling in Response to Genotoxic Stimuli , 2006, Science.
[202] Shao-Cong Sun,et al. Regulation of T cell development by the deubiquitinating enzyme CYLD , 2006, Nature Immunology.
[203] K. N. Pennington,et al. In Vivo Identification of Inducible Phosphoacceptors in the IKKγ/NEMO Subunit of Human IκB Kinase* , 2003, Journal of Biological Chemistry.
[204] M. Karin,et al. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.